주식회사 이엠비제약
주식회사 이엠비제약's KOBDi Score is 48.34 as of Sep 2026, down 5.77 points since Apr 2025; it rose in 2 and fell in 1 of the 12 monthly updates. As of Sep 2026 it is ahead of about 11% of companies in its industry, against 11% in Aug 2026 and the lower 10% in Apr 2025. Its strongest position was 12% (Jun 2026) and its weakest the lower 10% (Aug 2025).
A year earlier, in Aug 2025, its score was 45.79 and it was in the lower 10% of its industry.
| Sep 2026 | 48.34 | ahead of 11% |
| Aug 2026 | 48.34 | ahead of 11% |
| Jul 2026 | 48.34 | ahead of 11% |
| Jun 2026 | 48.34 | ahead of 12% |
| May 2026 | 48.34 | ahead of 11% |
| Apr 2026 | 48.34 | ahead of 11% |
| Mar 2026 | 48.34 | ahead of 11% |
| Feb 2026 | 48.34 | ahead of 11% |
| Dec 2025 | 48.18 | ahead of 11% |
| Aug 2025 | 45.79 | lower 10% |
| Jul 2025 | 45.79 | lower 10% |
| May 2025 | 54.11 | lower 10% |
| Apr 2025 | 54.11 | lower 10% |
| # | ||||
|---|---|---|---|---|
| 주식회사 제이비바이오텍 JB Biotech Inc. | 5–9 | #218 | ||
| (주)돌나라한농제약 Doalnara Hannong Pharmaceutical., Co. Ltd | 5–9 | #217 | ||
| 주식회사 밸리 Valley Co., Ltd. | 5–9 | #220 | ||
| 주식회사 유한메디카 Yuhan Medica Corporation | 5–9 | #216 | ||
| 한국휴텍스제약(주) 안양공장 | 10–19 | #215 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is 주식회사 이엠비제약 located?
주식회사 이엠비제약 is registered at Jeonpa-ro 24beon-gil, Manan-gu, Anyang-si, Gyeonggi-do, part of the 4th floor and part of the 1st floor, South Korea (postal code 14087).
What industry is 주식회사 이엠비제약 in?
주식회사 이엠비제약 belongs to Manufacturing › Pharmaceuticals & Biologics › Finished pharmaceutical manufacturing.
What is 주식회사 이엠비제약's KOBDi Score?
48.34 as of September 2026, ahead of about 11% of companies in its industry.
Who are 주식회사 이엠비제약's competitors?
Similar companies include JB Biotech, Doalnara Hannong Pharmaceutical and Valley.

